Decision Aids to Improve Knowledge in Patients With Prostate Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Jon C. Tilburt, M.D.
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Alaska Native Tribal Health Consortium
Anchorage, Alaska, United States
- Mayo Clinic
Scottsdale, Arizona, United States
- Metrohealth Medical Center Urology Institute
Cleveland, Ohio, United States
- University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Regional Health
Rapid City, South Dakota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jul 2017
- Primary completion
- 4 Feb 2022
- Completion
- 4 Feb 2022
- Last update posted
- 2 Aug 2023
- Registered enrollment
- 103
- Registry id
- NCT03182998
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.